Chemotherapy Magazine Vaccines 
Pharmaceutical Technology
JULY 1, 2025
How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Sign up Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi.
Pharmaceutical Technology
JULY 4, 2025
How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 1, 2025
How will RFK Jr’s American dream for vaccines play out? In June 2025, the European Commission authorised Takeda’s Adcetris (brentuximab vedotin), an antibody-drug conjugate, combined with chemotherapy for treating adults who are newly diagnosed with Stage IIb Hodgkin’s lymphoma with risk factors or at Stage III/IV.
Pharmaceutical Technology
JULY 4, 2025
How will RFK Jr’s American dream for vaccines play out? Go deeper with GlobalData Reports LOA and PTSR Model - Denosumab Biosimilar in Bone Metastasis Reports LOA and PTSR Model - Denosumab Biosimilar in Chemotherapy Effects Data Insights The gold standard of business intelligence. Find out more Sign up for our daily news round-up!
Pharmaceutical Technology
JULY 7, 2025
How will RFK Jr’s American dream for vaccines play out? Find out more J&J’s drug is an option for patients where medical or surgical treatment to lower testosterone levels has not worked, and in those who have BRCA 1/2 mutations – a subset of homologous recombination repair (HRR) mutations – in whom chemotherapy is not indicated.
Pharmaceutical Technology
JULY 4, 2025
How will RFK Jr’s American dream for vaccines play out? Imfinzi is now approved to treat adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with chemotherapy drugs gemcitabine and cisplatin as neoadjuvant treatment, and as a monotherapy after bladder removal surgery.
Pharmaceutical Technology
JULY 3, 2025
How will RFK Jr’s American dream for vaccines play out? This approval makes Zegfrovy the only targeted oral treatment available in the US for NSCLC.
Expert insights. Personalized for you.
Let's personalize your content